Atlas Trials

A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension

Clinical trial NCT03492177 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03492177
Sponsor
Actelion
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2018-07-23
Primary completion
2022-03-28
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.